Accordingly, in prostate cancer cells the inhibition of SR-BI expression was shown to reduce cell viability31 and a positive correlation was found between elevated SR-BI expression and tumour grade, metastasis and poorer patient outcomes32. Here, SCARB1 is linked to prostate cancer.